EDSA

3.58% -0.1566

アフターアワーズ： 4.60 0.3876 +9.20%

Edesa Biotech Inc (EDSA)

Relative Volume:

ネットキャッシュフロー:

Edesa Biotech Inc Stock (EDSA) Company Profile

Edesa Biotech Inc

(905) 475-1234

100 SPY COURT, MARKHAM, ON

EDSA's Discussions on Twitter

Edesa Biotech Inc (EDSA) 最新ニュース

Edesa Biotech Inc (EDSA) 財務データ

Edesa Biotech Inc (EDSA)

Edesa Biotech Inc Stock (EDSA) Company Profile

Edesa Biotech Inc (EDSA) 最新ニュース

Pardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc. - GlobeNewswire Inc.

S&P Smallcap 600 (IQY) QuotePress Release - The Globe and Mail

1 Dividend Stock to Invest in the Domestic Steel Market Now - The Globe and Mail

Celsius Holdings Inc (CELH-Q) QuotePress Release - The Globe and Mail

Mackenzie Investments Announces Results of Special Meetings on Mutual Fund and ETF Mergers - Yahoo Canada Finance

ECB interest rate cut likely as Eurozone economy weaker than expected - Yahoo Finance UK

Veradigm Named as the Top Vendor for End-to-End Revenue Cycle Management Solutions - Yahoo Finance UK

Santander starts $1.7 billion share buyback programme - Yahoo Finance UK

FY2024 Earnings Estimate for Edesa Biotech, Inc. (NASDAQ:EDSA) Issued By HC Wainwright - Defense World

H.C. Wainwright bullish on Edesa Biotech stock amid BARDA study support - Investing.com

Edesa Biotech’s (EDSA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

500: Something went wrong - Investing.com UK

Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results - GlobeNewswire

Edesa Biotech (NASDAQ:EDSA) Stock Price Down 2% - Defense World

Edesa Biotech Inc expected to post a loss of 58 cents a shareEarnings Preview - XM

Ethiopian Airlines posts 14% jump in full-year revenue - Yahoo Finance UK

Alexis Shamess | Corporate/Commercial Lawyer in Toronto | People - Fasken

Myroslav Chwaluk | Mergers & Acquisitions Lawyer in Toronto | People - Fasken

A. Wojtek BaraniakPolish-speaking Corporate/Commercial lawyer in Toronto | People - Fasken

MoneySmart’s June Lucky Draw 2024 - Yahoo Finance

Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for antibody-drug conjugate with first-in-class potential - Yahoo Finance UK

Homebuilder Vistry boosts output target as cost inflation softens - Yahoo Finance UK

German environmental authorities approve Tesla site expansion - Yahoo Finance UK

Cipher Pharmaceuticals - The Pharma Letter

Edesa Biotech (NASDAQ:EDSA) Receives Buy Rating from HC Wainwright - Defense World

Allied gaming executive Choi buys shares worth $778k By Investing.com - Investing.com

Bioventus exec sells over $14k in company stock By Investing.com - Investing.com

Edesa's Paridiprubart Selected for U.S.-Funded Platform Trial in General ARDS - Contract Pharma

BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS - StockTitan

Edesa’s Paridiprubart Selected For U.S.-Funded Platform Trial In General ARDS - Contract Pharma

Comparing Assertio (NASDAQ:ASRT) and Edesa Biotech (NASDAQ:EDSA) - Defense World

Short Interest in Edesa Biotech, Inc. (NASDAQ:EDSA) Rises By 32.1% - Defense World

Perritt Capital Management Inc. Has $482000 Stake in Usio, Inc. (NASDAQ:USIO) - Defense World

Anixa Biosciences director buys shares worth over $1,000 By Investing.com - Investing.com

Stephens Inc. AR Has $1.30 Million Stock Holdings in DuPont de Nemours, Inc. (NYSE:DD) - Defense World

French jet engine maker Safran gets Italy's clearance to buy Microtecnica - Yahoo Finance UK

Edesa Biotech Shareholders Approve Board and Compensation PlansTipRanks.com - TipRanks

Edesa Biotech, Inc. Forecasted to Earn FY2024 Earnings of ($1.95) Per Share (NASDAQ:EDSA) - Defense World

FY2024 EPS Estimates for HEICO Co. Lifted by Analyst (NYSE:HEI) - Defense World

EDSA: Preparing IND for Phase 2 Trial of EB06 in Vitiligo - Zacks Small Cap Research

Kiora Pharmaceuticals (KPRX) Stock Forecast and Price Target 2024 - MarketBeat

EDSA Stock Earnings: Edesa Biotech Beats EPS for Q2 2024 - MSN

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results10.05.2024 - wallstreet:online

Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results | Regional | chronicle-tribune.com - Chronicle-Tribune

EDSA Stock Earnings: Edesa Biotech Beats EPS for Q2 2024 - InvestorPlace

Niagara Energy finalizes $1.36 billion takeover of Enel Peru unit - Yahoo Finance UK

Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer - BioSpace

Edesa Biotech CEO acquires $20k in company shares By Investing.com - Investing.com

Edesa Biotech to Participate in Upcoming Dermatology Meetings - Yahoo Finance

EDSA Stock Quote Price and Forecast - CNN

Edesa Biotech Reports Fiscal 1st Quarter 2024 Results - Yahoo Finance

Edesa Biotech Inc (EDSA) 財務データ

収益

当期純利益

現金流量

EPS

EDSAに似た銘柄